Diadem SpA, a company developing AlzoSure Predict, the first blood-based test for the early prediction of progression to Alzheimer's disease (AD), announced that is...
Diadem SpA announced publication of the results of a clinical validation study of its AlzoSure Predict prognostic blood test for Alzheimer's disease (AD). The...